Data shows ‘pharmacy lobby’ were wrong: AMA

packs of OTC codeine
Low-dose codeine preparations featuring obsolete S3 packaging.
The AMA says that recent TGA data has “vindicated” the decision to upschedule low-dose codeine Several days ago, the TGA issued a report which analysed pharmaceutical industry sales data and found that the total number of codeine-containing products supplied in Australia was around 50% lower than the average total supplied in the previous four years.

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Hazzard rejects UTI pharmacist prescribing proposal
Next What's in a name?